Skip to main content

Table 1 Basic clinical characteristics of women with GDM and controls

From: Subclinical inflammation associated with prolonged TIMP-1 upregulation and arterial stiffness after gestational diabetes mellitus: a hospital-based cohort study

 

GDM

Controls

p value

Average time since delivery, years

3.7 ± 1.0

3.7 ± 0.9

0.818

Age, years

35.8 ± 4.4

35.9 ± 4.6

0.854

Primiparous, n (%)

23 (19.2%)

23 (19.2%)

1.000

Therapy of GDM during pregnancy

 Insulin, n (%)

24 (20.0%)

  

 Metformin, n (%)

1 (0.8%)

  

 Dietary therapy, n (%)

95 (79.2%)

  

Pack-years of smoking

3.8 ± 6.0

2.4 ± 4.6

0.012

During the previous month, history of

 Respiratory infection, n (%)

45 (37.5%)

44 (36.7%)

0.854

 Other infectious disease, n (%)

18 (15.0%)

10 (8.3%)

0.053

 Trauma, n (%)

9 (7.5%)

5 (4.2%)

0.264

BMI, kg/m2

28.3 ± 5.0

27.5 ± 5.4

0.069

Systolic BP, mmHg

122.4 ± 12.5

119.0 ± 11.5

0.034

Diastolic BP, mmHg

73.5 ± 9.0

71.8 ± 8.7

0.176

Heart rate, beats per minute

65.9 ± 9.1

63.8 ± 9.6

0.017

TC, mmol/L

4.7 ± 0.9

4.6 ± 0.8

0.329

F-Gluc, mmol/L

5.6 ± 0.6

5.3 ± 0.3

<0.001

F-Insu, mU/L

5.2 ± 3.6

4.6 ± 3.6

0.087

  1. Data are presented as mean ± SD if not mentioned otherwise
  2. BMI body mass index, BP blood pressure, F-Gluc fasting glucose, F-Insu fasting insulin, TC total cholesterol